Effectiveness and Safety of Ginger in the Treatment of Pregnancy-Induced Nausea and Vomiting

Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy.
Obstetrics and Gynecology (Impact Factor: 5.18). 05/2005; 105(4):849-56. DOI: 10.1097/01.AOG.0000154890.47642.23
Source: PubMed


Conventional antiemetics are burdened with the potential of teratogenic effects during the critical embryogenic period of pregnancy. Thus, a safe and effective medication would be a welcome addition to the therapeutic repertoire. This systematic review was aimed at assessing the evidence for or against the efficacy and safety of ginger (Zingiber officinale) therapy for nausea and vomiting during pregnancy.
Systematic literature searches were conducted in 3 computerized databases (MEDLINE, EMBASE, and Cochrane Library), and the reference lists of all papers located were checked for further relevant publications.
For the evaluation of efficacy, only double-blind, randomized controlled trials (RCTs) were included. All retrieved clinical data, including uncontrolled trials, case reports, observational studies, and RCTs, were included in the review of safety.
Six double-blind RCTs with a total of 675 participants and a prospective observational cohort study (n = 187) met all inclusion criteria. The methodological quality of 4 of 5 RCTs was high. Four of the 6 RCTs (n = 246) showed superiority of ginger over placebo; the other 2 RCTs (n = 429) indicated that ginger was as effective as the reference drug (vitamin B6) in relieving the severity of nausea and vomiting episodes. The observational study retrieved and RCTs (including follow-up periods) showed the absence of significant side effects or adverse effects on pregnancy outcomes. There were no spontaneous or case reports of adverse events during ginger treatment in pregnancy.
Ginger may be an effective treatment for nausea and vomiting in pregnancy. However, more observational studies, with a larger sample size, are needed to confirm the encouraging preliminary data on ginger safety.

Download full-text


Available from: Francesca Borrelli, Oct 13, 2014

Click to see the full-text of:

Article: Effectiveness and Safety of Ginger in the Treatment of Pregnancy-Induced Nausea and Vomiting

236.73 KB

See full-text
  • Source
    • "Currently no clear guidelines are available for ginger’s use in the treatment of NVP, despite some literature available on the subject [10,16,17]. A systematic review of the available literature (also focusing on safety aspects) can provide the best current evidence regarding possible benefits or risks for the clinical use of ginger to treat NVP. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and objectives: Nausea and vomiting during pregnancy (NVP) occur commonly. Possible harmful side-effects of conventional medicine to the fetus create the need for alternative options to relieve NVP. This systematic review (SR) investigated current evidence regarding orally administered ginger for the treatment of NVP. The primary objective was to assess the effectiveness of ginger in treating NVP. The secondary objective was to assess the safety of ginger during pregnancy. A comprehensive electronic bibliographic database search was carried out. Randomized controlled trials (RCTs) of the efficacy of orally administered ginger, as treatment for NVP in pregnant women at any stage of pregnancy, published in English, were included. Two researchers independently extracted data and assessed trial quality. RevMan5 software (Cochrane Collaboration) was used for data analysis. p < 0.05 was considered statistically significant. Twelve RCTs involving 1278 pregnant women were included. Ginger significantly improved the symptoms of nausea when compared to placebo (MD 1.20, 95% CI 0.56-1.84, p = 0.0002, I2 = 0%). Ginger did not significantly reduce the number of vomiting episodes during NVP, when compared to placebo, although there was a trend towards improvement (MD 0.72, 95% CI -0.03-1.46, p = 0.06, I2 = 71%). Subgroup analyses seemed to favor the lower daily dosage of <1500 mg ginger for nausea relief. Ginger did not pose a significant risk for spontaneous abortion compared to placebo (RR 3.14, 95% CI 0.65-15.11, p = 0.15; I2 = 0%), or to vitamin B6 (RR 0.49, 95% CI 0.17-1.42, p = 0.19, I2 = 40%). Similarly, ginger did not pose a significant risk for the side-effects of heartburn or drowsiness. This review suggests potential benefits of ginger in reducing nausea symptoms in pregnancy (bearing in mind the limited number of studies, variable outcome reporting and low quality of evidence). Ginger did not significantly affect vomiting episodes, nor pose a risk for side-effects or adverse events during pregnancy. Based on evidence from this SR, ginger could be considered a harmless and possibly effective alternative option for women suffering from NVP.International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42011001237.
    Nutrition Journal 03/2014; 13(1):20. DOI:10.1186/1475-2891-13-20 · 2.60 Impact Factor
  • Source
    • "Although this symptom gets spontaneously recovered with the time passing, it can place a great stress on the pregnant woman and those around her and disturb her work so that, in 25% of cases, the employed pregnant women often require a leave. This symptom can even lead to depression [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. Comparing the effectiveness of vitamin B6 (40 mg twice daily) and ginger (250 mg four times daily) in treatment of pregnancy nausea. Methods. In a clinical trial in health centers of Qazvin University of Medical Sciences from November 2010 to February 2011 on pregnant mothers, the effects of vitamin B6 (40 mg twice daily) and ginger (250 mg four times daily) were evaluated in treatment of pregnancy nausea. Results. In both groups, treatments with vitamin B6 or ginger led to significant reduction in MPUQE score. Scores of symptoms at the day before treatment in vitamin B6 and ginger groups were 9.35 ± 1.97 and 9.80 ± 2.03, respectively, and reduced to 5.98 ± 1.45 and 6.28 ± 1.63, respectively, in the fourth day of treatment; however, mean changes in the two groups were not significantly different. Mean changes of MPUQE score in ginger and vitamin B6 groups were 8.32 ± 2.19 and 7.77 ± 1.80, respectively, showing no significant difference (P = 0.172). Conclusion. Vomiting was more reduced in vitamin B6 group; however, this reduction was not statistically significant. There was no significant difference between the two groups in nausea occurrences and their duration. No side effect was observed in either group.
    Obstetrics and Gynecology International 10/2013; 2013:927834. DOI:10.1155/2013/927834
  • Source
    • "If ginger is to be used in medicinal purposes, then the determination of its major components should be characterized and standardized. None of the ginger powders or extracts used during the previous clinical trial were analyzed prior to use (Vutyavanich et al. 2001; Keating and Chez 2002; Willetts et al. 2003; Borrelli et al. 2005; Chrubasik et al. 2005), and this lead to a major limitation of these studies. Moreover, major components of ginger such as 6-gingerol have been shown to exhibit antioxidant and anti-inflammatory properties (Kiuchi et al. 1992; Phan et al. 2005) to suppress cytokine formation (Kjuchi et al. 1992; Phan et al.) and to promote angiogenesis (Kim et al. 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Randomly amplified polymorphic DNA (RAPD) and inter-simple sequence repeat (ISSR) markers were used to analyze the genetic stability of ten local cultivars collected fromManipur, India with the released ginger variety Nadia. A total of 15 RAPD and 8 ISSR primers resulted in 107 and 53 distinct and reproducible bands, respectively. A lack of polymorphism revealed the genetic stability among the local cultivars. Unlike molecular markers, analysis of essential oil composition by gas chromatography–mass spectrometry (GC-MS) revealed variation among 11 clones. Among the eight major constituents determined by GC-MS, cinnamyl acetate was found only in one cultivar, whereasa different cultivar did not contain any trans-geraniol. These variations indicated the presence of polymorphism among local cultivars.
    Analytical Letters 06/2013; · 1.03 Impact Factor
Show more